featured
Exudative Recurrence Rates for Eyes With Inactivated Wet AMD on 12-Week Interval Dosing With Bevacizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Retina (Philadelphia, Pa.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rates of Exudative Recurrence for Eyes With Inactivated Wet Age-Related Macular Degeneration on 12-Week Interval Dosing With Bevacizumab Therapy
Retina (Philadelphia, Pa.) 2019 Jan 14;[EPub Ahead of Print], RY Hwang, D Santos, SCN OliverFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.